Study Notes on GABA
Overview of GABA
GABA stands for gamma-aminobutyric acid.
It is a simple neurotransmitter with complex functions in the central nervous system.
The discussion covers GABA's synthesis, receptor functioning, and related pathology.
GABA Cycle
The basic GABA pathway involves:
GABA release from the presynaptic neuron.
Reuptake of GABA by the same neuron.
Repackaging into vesicles for future release.
A more complex pathway includes:
Uptake by astrocytes.
Transformation through the citric acid cycle and conversion into glutamine.
Neurotransmitter Release and Reuptake
Following release into the synapse, GABA is taken back up via:
GABA Transporters (GAT): Responsible for GABA transport into neurons and astrocytes.
GAT1: Present in GABAergic neurons.
GAT3: Present in astrocytes; both GAT1 and GAT3 perform similarly in function.
After entering astrocytes, GABA is transported into mitochondria with the help of:
Galapermease: Facilitates the uptake of GABA for metabolism.
GAD67: An enzyme broadly expressed in the cell, responsible for nonsynaptic GABA production, aiding synaptogenesis (the creation of new synapses).
Vesicular GABA Transporter (VGAT): An antiporter that exchanges protons and GABA, using an ATP-powered proton pump to create an ion gradient in vesicles.
Pathway Functions
GABA can undergo:
GABA Transaminase Reaction: Converts GABA back into the TCA (tricarboxylic acid) cycle as alpha-ketoglutarate, acting as a source of energy when necessary.
Receptor Types
GABA Receptors
GABA A Receptors:
Ion channels that primarily allow chloride ions to flow.
Require binding of two GABA molecules to open fully.
Pentameric structure typically consisting of:
2 alpha subunits
2 beta subunits
1 gamma subunit
Function varies by combinations of additional subunits (delta, epsilon, theta, pi).
GABA B Receptors:
G protein-coupled receptors (GPCRs) that modulate synaptic transmission (fewer receptors activated by one GABA molecule).
GABA C Receptors:
Older classification, mostly contain the rho subunit now referred to collectively with GABA A receptors.
Binding Sites of GABA A Receptors
Orthosteric Sites: Where GABA binds to activate ion flow.
Allosteric Sites (BZ Site): Target for drugs like benzodiazepines that modulate receptor activity, enhancing GABA's effects on chloride ion flow.
Ethanol acts similarly but binds to different subtypes of subunits.
Channel Blockers: Such as picotoxin, can inhibit chloride ion flow, used in research for seizure studies.
Neurophysiological Effects
GABA A receptor activation leads to:
Hyperpolarization of postsynaptic neurons through chloride influx, making action potential firing less likely.
In immature neurons, GABA's effect can be opposite:
Elevated intracellular chloride levels can lead to depolarization instead of hyperpolarization due to the action of the transporter MKCC1 (moving chloride, sodium, and potassium into the cell).
GABAergic Synapse Formation
Nurexin and Neuroligand Interactions:
Nurexin (presynaptic) binds to neuroligand 2 (postsynaptic) facilitating synapse anchoring by connecting proteins and signaling.
Jeffrin: A complex protein forming a scaffold in postsynaptic membranes, critical for maintaining the structural integrity of GABA A receptors and other synaptic proteins.
GAD Enzymes
GAD67 and GAD65 Differences:
GAD65: Associated with neurotransmitter release from vesicles.
GAD67: Involved in tonic inhibition through nonsynaptic GABA, contributing to cell protection and synaptic development.
Mutations in these can affect synaptic transmission and nonsynaptic GABA levels, impacting overall neuronal excitability.
Pharmacological Implications
Understanding GABA's mechanisms can illustrate pathways affected by drugs like:
Benzodiazepines (positive allosteric modulators of GABA A).
Alcohol (also a positive allosteric modulator).
Withdrawal from these substances can result in increased risk of seizures and excitatory states due to decreased inhibition.
Summary and Contextual Applications
Role of GABA in maintaining neuroinhibitory balance is essential in preventing various pathologies such as:
Seizures, anxiety disorders, and epilepsy.
Autism spectrum disorders linked to GABA signaling disruptions.
Ongoing research into GABA-related pathways holds promise for treatments and understanding of neurological disorders.